摘要
目的探析抑郁症运用改良森田疗法合并药物治疗的临床效果和安全性。方法选择抑郁症患者106例为研究对象,根据入院编号的偶数和奇数将其分为观察组与对照组,各53例。其中给予对照组常规药物治疗,而观察组则运用改良森田疗法和药物联合治疗,对两组的治疗效果和不良反应发生率进行对比分析。结果治疗前,两组的汉密尔顿抑郁量表(HAMD)评分比较无明显差异;治疗后,与对照组相比,观察组的HAMD评分明显下降,组间比较差异有统计学意义(P<0.05);同时,两组在治疗总有效率和不良反应发生率方面比较差异具有统计学意义(P<0.05)。结论临床上运用改良森田疗法和药物联合治疗抑郁症,具有不良反应小、疗效确切、安全性高等诸多优点,是值得推广运用的一种方法。
Objective To explore the clinical effect and safety of modified Morita therapy combined with drug therapy in depression. Methods Sixty -six patients with depressive disorder were selected and divided into observation group and control group according to the even and odd numbers of admission. The control group was given conventional drug therapy, while the observation group was improved using Morita therapy and drug combination therapy, the two groups of the treatment effect and incidence of adverse reactions were analyzed. Results After treatment, there was no significant difference in Hamilton Rating Scale （HAMD） scores between the two groups. After treatment, the HAMD scores of the observation group were significantly lower than those of the control group （P 〈0.05） There was significant difference between the two groups in the total effective rate and adverse reaction rate （P 〈0.05）. Conclusion The combination of modified Morita therapy and drugs in the treatment of depression has many merits, such as small adverse reaction, definite effect and high safety. It is a method worthy of popularization and application.
出处
《当代医学》
2017年第3期137-139,共3页
Contemporary Medicine
关键词
抑郁症
改良森田疗法
疗效
安全性
Depression
Modified Morita therapy
Efficacy
Safety
